Guangzhou Baiyunshan Pharmaceutical Sets 21 August 2026 Board Meeting to Review H1 2026 Unaudited Results

Bulletin Express

Aug 10

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced that its board of directors will convene on 21 August 2026 to consider and approve the unaudited financial results for the six months ended 30 June 2026. Additional business matters, if any, may also be addressed at the session.

The notice was issued from Guangzhou on 10 August 2026. As disclosed, the Board currently comprises six executive directors—Chen Jiehui, Yuan Cheng, Cheng Hongjin, Tang Heping, Liu Lan and Liu Hong—one non-executive director, Huang Jiyuan, and four independent non-executive directors: Wong Lung Tak Patrick, Sun Baoqing, Wu Xiangneng and Yang Yinbao.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1162133779"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1162133779\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1162133779?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-10 17:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1162133779","market":"us","top_or_hot":-1,"title":"Guangzhou Baiyunshan Pharmaceutical Sets 21 August 2026 Board Meeting to Review H1 2026 Unaudited Results","media":"Bulletin Express","content":"<p>Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced that its board of directors will convene on 21 August 2026 to consider and approve the unaudited financial results for the six months ended 30 June 2026. Additional business matters, if any, may also be addressed at the session.</p>\n<p>The notice was issued from Guangzhou on 10 August 2026. As disclosed, the Board currently comprises six executive directors—Chen Jiehui, Yuan Cheng, Cheng Hongjin, Tang Heping, Liu Lan and Liu Hong—one non-executive director, Huang Jiyuan, and four independent non-executive directors: Wong Lung Tak Patrick, Sun Baoqing, Wu Xiangneng and Yang Yinbao.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guangzhou Baiyunshan Pharmaceutical Sets 21 August 2026 Board Meeting to Review H1 2026 Unaudited Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuangzhou Baiyunshan Pharmaceutical Sets 21 August 2026 Board Meeting to Review H1 2026 Unaudited Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-10 17:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced that its board of directors will convene on 21 August 2026 to consider and approve the unaudited financial results for the six months ended 30 June 2026. Additional business matters, if any, may also be addressed at the session.</p>\n<p>The notice was issued from Guangzhou on 10 August 2026. As disclosed, the Board currently comprises six executive directors—Chen Jiehui, Yuan Cheng, Cheng Hongjin, Tang Heping, Liu Lan and Liu Hong—one non-executive director, Huang Jiyuan, and four independent non-executive directors: Wong Lung Tak Patrick, Sun Baoqing, Wu Xiangneng and Yang Yinbao.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00874","symbol_name":"白云山","start_time":0,"source_url":"","article_id":"1162133779","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1162133779","pubTimestamp":1786355142,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced that its board of directors will convene on 21 August 2026 to consider and approve the unaudited financial results for the six...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00874":"白云山"},"translate_title":"广州白云山药业于2026年8月21日召开董事会会议，审阅2026年上半年未经审核业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00874":1},"content_text":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited announced that its board of directors will convene on 21 August 2026 to consider and approve the unaudited financial results for the six months ended 30 June 2026. Additional business matters, if any, may also be addressed at the session.\nThe notice was issued from Guangzhou on 10 August 2026. As disclosed, the Board currently comprises six executive directors—Chen Jiehui, Yuan Cheng, Cheng Hongjin, Tang Heping, Liu Lan and Liu Hong—one non-executive director, Huang Jiyuan, and four independent non-executive directors: Wong Lung Tak Patrick, Sun Baoqing, Wu Xiangneng and Yang Yinbao.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}